FDA NDC Directory · JSON-LD · Markdown

Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 KwikPen

NDC 0002-8233 · HUMAN PRESCRIPTION DRUG · INJECTION, SUSPENSION

Generic nameInsulin lispro
Labeler / ManufacturerEli Lilly and Company
Marketing categoryBiologic License Application · App BLA021017
Dosage form / routeINJECTION, SUSPENSION · SUBCUTANEOUS
Active ingredientsINSULIN LISPRO (100 [iU]/mL)
Marketing started20200212
Package count1

External sources

Source: openFDA. Public-domain (CC0).